Evidence map›Paper›PMID 28408942›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2017

Identification of Tengfu Jiangya Tablet Target Biomarkers with Quantitative Proteomic Technique.

Jingwen Xu, Yunlun Li, Shijun Zhang, Haiqiang Jiang, Nan Wang, Haiqing Lin

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jingwen XuShandong University of Traditional Chinese Medicine, 4655 Daxue Road, Changqing District, Jinan, Shandong, China.
Yunlun LiShandong University of Traditional Chinese Medicine, 4655 Daxue Road, Changqing District, Jinan, Shandong, China.ORCID 0000-0002-2129-1447
Shijun ZhangShandong University of Traditional Chinese Medicine, 4655 Daxue Road, Changqing District, Jinan, Shandong, China.
Haiqiang JiangShandong University of Traditional Chinese Medicine, 4655 Daxue Road, Changqing District, Jinan, Shandong, China.
Nan WangShandong Tumor Hospital, 440 Jiyan Road, Jinan, Huaiyin District, Shandong, China.
Haiqing LinAffiliated Hospital of Shandong University of Traditional Chinese Medicine, 16369 Jingshi Road, Lixia District, Jinan, Shandong, China.
Shandong University of Traditional Chinese Medicine · CNAffiliated Hospital of Shandong University of Traditional Chinese Medicine · CNShandong Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tengfu Jiangya Tablet (TJT) is a well accepted antihypertension drug in China and its major active components were

Identifiers

PMID28408942
PMCPMC5376940
OpenAlexW2597467447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.